BioSpace News Archive

InnoCare Pharma, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced the Company presented the pre-clinical data of its pan-TRK small molecule inhibitor ICP-723 at the 113th annual meeting of the American Association for Cancer Research in 2022.

BioNTech SE presented data from its ongoing first-in-human Phase 1/2 trial evaluating the safety and preliminary efficacy of the Company’s novel CAR-T cell therapy candidate, BNT211, in patients with advanced solid tumors.

4TEEN4 pharmaceuticals GmbH announces that its biomarker DPP3 will be used in a biomarker-guided trial in severe COVID-19 as communicated by the University Hospital Hamburg-Eppendorf and SphingoTec GmbH.

Veru Inc., an oncology biopharmaceutical company, announced positive efficacy and safety results from a planned interim analysis of the double-blind, randomized, placebo-controlled Phase 3 COVID-19 clinical trial evaluating oral sabizabulin 9 mg versus placebo in 150 hospitalized COVID-19 patients at high risk for Acute Respiratory Distress Syndrome.

SQZ Biotechnologies, focused on unlocking the full potential of cell therapies for multiple therapeutic areas, shared enhanced antigen presenting cell preclinical data demonstrating that delivery of multiple mRNAs encoding for disease-specific antigens together with immune stimulators had a synergistic effect that substantially increased killer T cells in humanized mouse models.

Evofem Biosciences, Inc., announced the appointment of Karina Fedasz as its Head of Business Development.

NovaBay® Pharmaceuticals, Inc., a company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that Chief Product Officer Audrey Kunin, MD will return to the QVC network as a live on-air guest to discuss DERMAdoctor’s problem-solving eczema treatment.

Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies, today announced that it plans to offer patients with dystrophic epidermolysis bullosa (DEB), who are enrolled in the GEM-3 open label extension study, the opportunity to be dosed in their homes by a health care professional (HCP).

Israeli startup Sanolla, which provides AI-powered primary care diagnostic solutions, announced that the FDA has granted 510(k) clearance for the clinical use of the AI-ready VoqXTM, the first stethoscope in the world that can listen to infrasound - acoustic waves that cannot be heard by humans.

Lipocine Inc., a biopharmaceutical company focused on neuroendocrine and metabolic disorders, announced the appointment of Jill M. Jene, Ph.D. and Spyros Papapetropoulos, M.D., Ph.D. to its board of directors.